Ramm Pharma (TSE:RAMM) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ramm Pharma Corp. has announced that the Ontario Superior Court of Justice has dismissed both the CAD 3,139,931.30 claim against them and their CAD 14,220,000 counterclaim in a legal dispute with Sergio Martines and Naturale Science Inc. The court did award a minor sum for unpaid expenses to Martines. Ramm continues its operations in cannabinoid pharmacology with a diversified portfolio in various international markets.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.